Vascular complications after percutaneous mitral valve repair and venous access closure using suture or closure device

Steppich, Birgit; Stegmüller, Felix Maximilian; Rumpf, P; Pache, Jürgen; Sonne, Carolin; Lesevic, Hasema; Braun, Daniel; Hausleiter, Jörg; Kasel, Albert M.; Ott, Ilka

doi:10.1111/joic.12459

Cited by 26 publications

(25 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, due to the elastic venous wall properties, the access site sealing and healing is fast and standard manual compression is an effective and safe method in achieving hemostasis. However, several studies have shown that temporary figure-of-eight suture (Z-suture) is a useful tool in achieving hemostasis by compression of the femoral vein through wrapped and folded subcutaneous soft tissue (14). On the other hand, preclosure suture with the Proglide® (Abbott Vascular Inc., Santa Clara, California) device for larger-sized venous sheaths proved to be safe and allowing an early mobilization (15).…”

Section: Introductionmentioning

confidence: 99%

Complications Following Percutaneous Mitral Valve Repair

Gheorghe

Ielasi

Rensing

et al. 2019

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Mitral valve disease affects more than 4 million people in the United States and it is the second most prevalent valvulopathy in Europe. The gold standard of treatment in these patients is surgical repair or mitral valve replacement. In the last decade, numerous transcatheter therapies have been developed to overcome the increased number of subjects with symptomatic severe mitral regurgitation and high surgical risk. The Mitraclip (Abbott Vascular, Menlo Park, CA), PASCAL (Edwards Lifesciences, Irvine, CA, USA), the Carillon™ Mitral Contour System™ (Cardiac Dimension Inc., Kirkland, WA, USA), the Mitralign™ (Mitralign, Tewksbury, Massachusetts), and the Cardioband (Edwards Lifesciences, Irvine, CA) are the principal percutaneous devices for mitral valve repair. We present an evidence-based clinical update that provides an overview of these technologies and their potential complications.

show abstract

Section: Introductionmentioning

confidence: 99%

Complications Following Percutaneous Mitral Valve Repair

Gheorghe

Ielasi

Rensing

et al. 2019

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…Previous studies have proved the safety and feasibility of the PVCD during interventional procedures [ 3 - 6 ]. In particular, ProGlide was found to perform better than other PVCDs in interventional research [ 9 - 13 ].…”

Section: Discussionmentioning

confidence: 99%

“…The traditional approach of femoral cannulation is to make a small incision in the inguinal area and to access the femoral vessels ( Fig. 3A, B ) [ 2 , 6 ]. The open surgical technique for femoral cannulation may have some disadvantages compared to percutaneous cannulation.…”

Section: Discussionmentioning

confidence: 99%

“…In this case, the characteristics of the surgical wound or the occurrence of complications, such as lymphocele and paresthesia, may decrease patients’ satisfaction with the surgery and increase the length of stay or frequency of hospital visits. From this point of view, percutaneous cannulation using PVCD can increase patient satisfaction related to the surgical wound and prevent complications, such as lymphocele and paresthesia [ 4 , 6 , 8 ]. In this study, no patient reported any complications related to the femoral wound ( Fig.…”

Section: Discussionmentioning

confidence: 99%

“…The use of PVCDs has been increasing concomitantly with the expansion of interventions after advances in technology and the accumulation of experience in clinical practice. Previous reports have confirmed the safety and effectiveness of PVCDs [3][4][5][6]. As clinicians have gained experience with using PVCDs, their use has expanded, including in the field of cardiac surgery [7].…”

Section: Introductionmentioning

confidence: 91%

See 2 more Smart Citations

Control of Femoral Cannulation with a ProGlide Pre-Closure Device during Cardiac Surgery: Is It Reliable?

Kim

Lim

et al. 2021

J Chest Surg

View full text Add to dashboard Cite

Background: The use of ProGlide as a percutaneous vascular closure device in cardiac surgery remains inconclusive. This study investigated the clinical outcomes of using Pro-Glide in the percutaneous cannulation of femoral vessels in adult cardiac surgery. Methods: From September 2017 to July 2018, 131 consecutive patients underwent femoral vessel cannulation during cardiac surgery. The ProGlide (Abbott Vascular Inc., Santa Clara, CA, USA) with percutaneous cannulation was used in 118 patients (mean age, 55.7±15.5 years). The accessibility of femoral cannulation was evaluated through preoperative computed tomography. For cannulation, sonography was routinely used. The postoperative ankle-brachial index (ABI) was used to evaluate femoral artery stenosis. Results: Of the 118 patients, 112 (94.9%) and 6 (5.1%) underwent minimally invasive cardiac surgery and median sternotomy, respectively. Most femoral cannulations were performed on the right side (98.3%) using 15F to 19F arterial cannulas. The technical success rate of cannulation with ProGlide was 99.2%, with no delayed bleeding or cannulation site-related complications during hospitalization. During follow-up, only 1 patient showed femoral artery stenosis with claudication and was treated with interventional balloon angioplasty. The postoperative ABI revealed no significant difference in functional stenosis between the cannulation and non-cannulation sides (n=86; cannulation vs. non-cannulation, 1.2±0.1 vs. 1.1±0). Conclusion:Percutaneous femoral cannulation with ProGlide was safe and feasible in adult cardiac surgery. This technique may be a good alternative option in patients requiring femoral vessel cannulation for cardiac surgery.

show abstract